Gallium-68 Edotreotide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gallium-68 Edotreotide, covering 2025-06-03 to 2025-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors [Phase 3]